Envestnet Asset Management Inc. lowered its stake in ARK Innovation ETF (NYSEARCA:ARKK – Free Report) by 8.9% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 312,341 shares of the company’s stock after selling 30,388 shares during the quarter. Envestnet Asset Management Inc. owned 0.21% of ARK Innovation ETF worth $13,727,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in ARKK. Jones Financial Companies Lllp purchased a new stake in ARK Innovation ETF during the 4th quarter valued at $26,000. Westside Investment Management Inc. grew its stake in shares of ARK Innovation ETF by 107.1% in the first quarter. Westside Investment Management Inc. now owns 580 shares of the company’s stock worth $29,000 after purchasing an additional 300 shares during the last quarter. Ashton Thomas Private Wealth LLC bought a new stake in shares of ARK Innovation ETF in the second quarter worth about $26,000. GoalVest Advisory LLC raised its position in ARK Innovation ETF by 124.8% during the 1st quarter. GoalVest Advisory LLC now owns 670 shares of the company’s stock valued at $34,000 after purchasing an additional 372 shares during the last quarter. Finally, Mather Group LLC. purchased a new stake in ARK Innovation ETF in the 1st quarter worth approximately $38,000.
ARK Innovation ETF Trading Up 1.1 %
Shares of ARKK stock opened at $47.45 on Wednesday. The business’s 50 day moving average price is $44.46 and its 200-day moving average price is $45.25. ARK Innovation ETF has a fifty-two week low of $33.76 and a fifty-two week high of $54.52.
ARK Innovation ETF Company Profile
The ARK Innovation ETF (ARKK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that seeks long-term capital growth from companies globally involved with, or that benefit from, disruptive innovation. ARKK was launched on Oct 31, 2014 and is managed by ARK.
Further Reading
- Five stocks we like better than ARK Innovation ETF
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Canadian Penny Stocks: Can They Make You Rich?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Quiet Period Expirations Explained
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for ARK Innovation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Innovation ETF and related companies with MarketBeat.com's FREE daily email newsletter.
